AngioDynamics (ANGO) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
AngioDynamics (ANGO) PT Raised to $13 at Oppenheimer
July 16, 2024 3:27 PM EDTOppenheimer analyst Steven M. Lichtman raised the price target on AngioDynamics (NASDAQ: ANGO) to $13.00 (from $12.00) while maintaining a Outperform rating.
The analyst comments "ANGO's F4Q24 sales of $71.1M (+1.9% y/y pro forma) were in line with the key higher margin/growth... More
